Food and Drug Administration Accelerated Approval of Lecanemab for Early Alzheimer's Disease—Hope, Reality, and the Unknown Going Forward : Clinical Nurse Specialist

Secondary Logo

Journal Logo

DEPARTMENTS: NCPD Test

Food and Drug Administration Accelerated Approval of Lecanemab for Early Alzheimer's Disease—Hope, Reality, and the Unknown Going Forward

Clinical Nurse Specialist 37(3):p E3, 5/6 2023. | DOI: 10.1097/NUR.0000000000000748
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid